InhibitorofTCF-dependenttranscription.BlocksBIO-inducedβ-cateninstABIlization;reducesnuclearandcytosolicβ-cateninlevelsinmouseL-cells.InhibitsgrowthandreducesTCF-dependenttranscriptioninSW480coloncarcinomacells.
CCT031374hydrobromideisalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
| M.Wt | 434.33 |
| Formula | C23H19N3O.HBr |
| Storage | DesiccateatRT |
| Purity | ≥98%(HPLC) |
| CASNumber | 1219184-91-4 |
| PubChemID | 18554738 |
| InChIKey | MPILENOYNNNGKO-UHFFFAOYSA-N |
| Smiles | O=C(C4=CC=C(C5=CC=CC=C5)C=C4)CN1C3=C(C=CC=C3)N2C1=NCC2.Br |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 21.72 | 50 |
Thefollowingdataisbasedontheproductmolecularweight434.33.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 2.3mL | 11.51mL | 23.02mL |
| 5mM | 0.46mL | 2.3mL | 4.6mL |
| 10mM | 0.23mL | 1.15mL | 2.3mL |
| 50mM | 0.05mL | 0.23mL | 0.46mL |



